Lack of correlation between angiogenic cytokines and serum insulin-like growth factor-1 in patients with multiple myeloma (Q43647817)

25 November 2017

title

Lack of correlation between angiogenic cytokines and serum insulin-like growth factor-1 in patients with multiple myeloma (English)

1 reference

25 November 2017

C A Pappa

1

1 reference

25 November 2017

G Tsirakis

2

1 reference

25 November 2017

F E Psarakis

3

1 reference

25 November 2017

A Kolovou

4

1 reference

25 November 2017

M Tsigaridaki

5

1 reference

25 November 2017

D Stafylaki

6

1 reference

25 November 2017

K Sfiridaki

7

1 reference

25 November 2017

M G Alexandrakis

8

1 reference

25 November 2017

language of work or name

1 reference

25 December 2012

1 reference

25 November 2017

1 reference

25 November 2017

volume

30

1 reference

25 November 2017

issue

1

1 reference

25 November 2017

page(s)

363

1 reference

https://scigraph.springernature.com/pub.10.1007/s12032-012-0363-0

25 November 2017

exact match

0 references

cites work

Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0363-0

Interleukin 6 induces the expression of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0363-0

Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0363-0

Hepatocyte growth factor promotes migration of human myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0363-0

Serum levels of interleukin-15 and interleukin-10 and their correlation with proliferating cell nuclear antigen in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0363-0

Induction of angiogenesis by normal and malignant plasma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0363-0

Multiple myeloma cells are protected against dexamethasone-induced apoptosis by insulin-like growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0363-0

Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0363-0

Specific roles for the PI3K and the MEK-ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0363-0

Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0363-0

Mechanism of STAT3 activation by insulin-like growth factor I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0363-0

Structure and function of the type 1 insulin-like growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0363-0

Secretion of insulinlike growth factor I and insulinlike growth factor-binding proteins by murine bone marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0363-0

The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0363-0

Reduction of serum IGF-I levels in patients affected with Monoclonal Gammopathies of undetermined significance or Multiple Myeloma. Comparison with bFGF, VEGF and K-ras gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0363-0

Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0363-0

The role of the insulin-like growth factor 1 receptor axis in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0363-0

IGF-1R is overexpressed in poor-prognostic subtypes of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0363-0

Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma

21 January 2018

1 reference

12 December 2020

In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma

1 reference

12 December 2020

Interleukin-6 in multiple myeloma: correlation with disease activity and Ki-67 proliferation index

1 reference

12 December 2020

A role for insulin-like growth factor in the regulation of IL-6-responsive human myeloma cell line growth

1 reference

12 December 2020

Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6.

1 reference

12 December 2020

CD221 (IGF-1R) is aberrantly expressed in multiple myeloma, in relation to disease severity

1 reference

12 December 2020

Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor

1 reference

12 December 2020

Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis

1 reference

12 December 2020

Novel therapeutic strategies targeting growth factor signalling cascades in multiple myeloma

1 reference

12 December 2020

Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma

1 reference

12 December 2020

Insulin-like growth factor-1 acts as a chemoattractant factor for 5T2 multiple myeloma cells

1 reference

12 December 2020

Cytokines prevent dexamethasone-induced apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in a new multiple myeloma cell line

1 reference

12 December 2020

Pro-inflammatory states and IGF-I level in ischemic heart disease with low or high serum iron

1 reference

12 December 2020

The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses.

1 reference

12 December 2020

In vivo induction of insulin-like growth factor-I receptor and CD44v6 confers homing and adhesion to murine multiple myeloma cells.

1 reference

12 December 2020

CD40 ligand triggered interleukin-6 secretion in multiple myeloma

1 reference

12 December 2020

Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines.

1 reference

12 December 2020

10.1007/S12032-012-0363-0

Identifiers

DOI

1 reference

Dimensions Publication ID

25 November 2017

1039620836

0 references

1 reference